These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22272086)

  • 1. Pilot study: alteration of deleted in liver cancer1 and phosphorylated focal adhesion kinase Y397 cytoplasmic expression and the prognostic value in advanced epithelial ovarian carcinoma.
    Fan DM; Shi HR
    Int J Mol Sci; 2011; 12(12):8489-501. PubMed ID: 22272086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium.
    Aust S; Auer K; Bachmayr-Heyda A; Denkert C; Sehouli J; Braicu I; Mahner S; Lambrechts S; Vergote I; Grimm C; Horvat R; Castillo-Tong DC; Zeillinger R; Pils D
    Mol Cancer; 2014 Mar; 13():67. PubMed ID: 24655477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of deleted in liver cancer 1 and phosphorelated focal adhesion kinase in breast cancer].
    Feng Y; Zhou HX; Li JH; Li ZY; Cheng WG; Jin ML; He L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1448-51. PubMed ID: 21868344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3.
    Shi H; Liu H; Zhao G
    Mol Biol Rep; 2012 Oct; 39(10):9299-306. PubMed ID: 22760257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance.
    Ren F; Shi H; Zhang G; Zhang R
    J Exp Clin Cancer Res; 2013 Aug; 32(1):60. PubMed ID: 23988121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
    Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
    Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
    J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
    Stone RL; Baggerly KA; Armaiz-Pena GN; Kang Y; Sanguino AM; Thanapprapasr D; Dalton HJ; Bottsford-Miller J; Zand B; Akbani R; Diao L; Nick AM; DeGeest K; Lopez-Berestein G; Coleman RL; Lutgendorf S; Sood AK
    Cancer Biol Ther; 2014 Jul; 15(7):919-29. PubMed ID: 24755674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
    Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
    Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
    Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLC1 expression is reduced in human cutaneous melanoma and correlates with patient survival.
    Sjoestroem C; Khosravi S; Cheng Y; Safaee Ardekani G; Martinka M; Li G
    Mod Pathol; 2014 Sep; 27(9):1203-11. PubMed ID: 24557030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concerted modulation of paxillin dynamics at focal adhesions by Deleted in Liver Cancer-1 and focal adhesion kinase during early cell spreading.
    Kaushik S; Ravi A; Hameed FM; Low BC
    Cytoskeleton (Hoboken); 2014 Dec; 71(12):677-94. PubMed ID: 25448629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.
    Shah NR; Tancioni I; Ward KK; Lawson C; Chen XL; Jean C; Sulzmaier FJ; Uryu S; Miller NL; Connolly DC; Schlaepfer DD
    Gynecol Oncol; 2014 Jul; 134(1):104-11. PubMed ID: 24786638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.
    Deng B; Zhao Y; Gou W; Chen S; Mao X; Takano Y; Zheng H
    Tumour Biol; 2013 Oct; 34(5):2617-24. PubMed ID: 23657964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer.
    Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G
    Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study.
    Gabriel B; Hasenburg A; Waizenegger M; Orlowska-Volk M; Stickeler E; zur Hausen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1221-5. PubMed ID: 19823058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.
    Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G
    J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.